Introduction: Analytical problems should be considered in case of a discrepancy between the results of biochemical tests and the clinical findings. Macro-hormones often artefactually elevate biochemical tests. Case Presentation: A young male was referred with persistently elevated TSH (148 mIU/L) measured by a sandwich electrochemiluminescence immunoassay, ECLIA (Cobas; Roche, Basel, Switzerland). The patient’s complaints were unspecific, and he appeared clinically euthyroid. The plasma levels of free T4 and free T3 were within the normal range, thyroid autoantibodies were negative, and thyroid ultrasonography was normal. During a short trial of thyroid hormone substitution, the level of TSH decreased to near-normal levels, but hyperthyroid symptoms emerged. TSH analysed by a different immunoassay (Architect; Abbott, Chicago, IL, USA) yielded similar results. In addition, serial dilutions were performed showing linearity, without detection of heterophilic antibody interference. Gel filtration chromatography confirmed the presence of macro-TSH. Conclusion: The patient harboured macro-TSH, which is a rare condition. The complex binding of TSH to other plasma proteins, most often immunoglobulins, results in elevated plasma TSH. However, the biologically active fraction of TSH is normal, reflected by clinical and biochemical euthyroidism.

1.
Hattori
N
,
Ishihara
T
,
Matsuoka
N
,
Saito
T
,
Shimatsu
A
.
Anti-Thyrotropin Autoantibodies in Patients with Macro-Thyrotropin and Long-Term Changes in Macro-Thyrotropin and Serum Thyrotropin Levels
.
Thyroid
.
2017
Feb
;
27
(
2
):
138
46
.
[PubMed]
1050-7256
2.
Favresse
J
,
Burlacu
MC
,
Maiter
D
,
Gruson
D
.
Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm
.
Endocr Rev
.
2018
Oct
;
39
(
5
):
830
50
.
[PubMed]
0163-769X
3.
Hattori
N
,
Aisaka
K
,
Chihara
K
,
Shimatsu
A
.
Current Thyrotropin Immunoassays Recognize Macro-Thyrotropin Leading to Hyperthyrotropinemia in Females of Reproductive Age
.
Thyroid
.
2018
Oct
;
28
(
10
):
1252
60
.
[PubMed]
1050-7256
4.
Hattori
N
,
Ishihara
T
,
Shimatsu
A
.
Variability in the detection of macro TSH in different immunoassay systems
.
Eur J Endocrinol
.
2016
Jan
;
174
(
1
):
9
15
.
[PubMed]
0804-4643
5.
Hattori
N
,
Ishihara
T
,
Yamagami
K
,
Shimatsu
A
.
Macro TSH in patients with subclinical hypothyroidism
.
Clin Endocrinol (Oxf)
.
2015
Dec
;
83
(
6
):
923
30
.
[PubMed]
0300-0664
6.
Mills
F
,
Jeffery
J
,
Mackenzie
P
,
Cranfield
A
,
Ayling
RM
.
An immunoglobulin G complexed form of thyroid-stimulating hormone (macro thyroid-stimulating hormone) is a cause of elevated serum thyroid-stimulating hormone concentration
.
Ann Clin Biochem
.
2013
Sep
;
50
(
Pt 5
):
416
20
.
[PubMed]
0004-5632
7.
Stephenson
A
,
Lau
L
,
Eszlinger
M
,
Paschke
R
.
The Thyrotropin Receptor Mutation Database Update
.
Thyroid
.
2020
Jun
;
30
(
6
):
931
5
.
[PubMed]
1050-7256
8.
Verhoye
E
,
Van den Bruel
A
,
Delanghe
JR
,
Debruyne
E
,
Langlois
MR
.
Spuriously high thyrotropin values due to anti-thyrotropin antibodies in adult patients
.
Clin Chem Lab Med
.
2009
;
47
(
5
):
604
6
.
[PubMed]
1434-6621
9.
Overgaard
M
,
Pedersen
SM
.
Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia
.
Clin Chem Lab Med
.
2017
Oct
;
55
(
11
):
1744
53
.
[PubMed]
1434-6621
10.
Loh
TP
,
Kao
SL
,
Halsall
DJ
,
Toh
SA
,
Chan
E
,
Ho
SC
, et al.
Macro-thyrotropin: a case report and review of literature
.
J Clin Endocrinol Metab
.
2012
Jun
;
97
(
6
):
1823
8
.
[PubMed]
0021-972X
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.